• Measure Summary
  • NQMC:008296
  • 2013 Jan

Chronic obstructive pulmonary disease (COPD): proportion of outpatients with COPD and a Medical Research Council (MRC) level of more than 3 who are offered participation in pulmonary rehabilitation at least once every three years.

Competence Centre for Clinical Quality and Health Informatics West; The Danish registry for Chronic Obstructive Pulmonary Disease

  • Measure Summary
  • NQMC:010540
  • 2015 Oct

Adherence to antipsychotic medications for individuals with schizophrenia: percentage of members 19 to 64 years of age during the measurement year with schizophrenia who were dispensed and remained on an antipsychotic medication for at least 80 percent of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010528
  • 2015 Oct

Statin therapy for patients with diabetes: percentage of members 40 to 75 years of age during the measurement year with diabetes who do not have ASCVD who remained on a statin medication of any intensity for at least 80% of the treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:008299
  • 2013 Jan

Chronic obstructive pulmonary disease (COPD): proportion of outpatients with COPD receiving inhalation therapy who have their inhaler technique checked at least once a year.

Competence Centre for Clinical Quality and Health Informatics West; The Danish registry for Chronic Obstructive Pulmonary Disease

  • Measure Summary
  • NQMC:010542
  • 2015 Oct
  • NQF-Endorsed Measure

Annual monitoring for patients on persistent medications: percentage of members 18 years of age and older who received at least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010525
  • 2015 Oct
  • NQF-Endorsed Measure

Comprehensive diabetes care: percentage of members 18 to 75 years of age with diabetes (type 1 and type 2) who received medical attention for nephropathy.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010517
  • 2015 Oct
  • NQF-Endorsed Measure

Persistence of beta-blocker treatment after a heart attack: percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for six months after discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010511
  • 2015 Oct

Pharmacotherapy management of COPD exacerbation: percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1 and November 30 of the measurement year and who were dispensed a systemic corticosteroid within 14 days of the event.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010565
  • 2015 Oct
  • NQF-Endorsed Measure

Flu vaccinations for adults ages 18 to 64: percentage of members 18 to 64 years of age who received an influenza vaccination between July 1 of the measurement year and the date when the CAHPS 5.0H Adult Survey was completed.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010514
  • 2015 Oct
  • NQF-Endorsed Measure

Medication management for people with asthma: percentage of members 5 to 85 years of age during the measurement year who were identified as having persistent asthma and who were dispensed an asthma controller medication that they remained on for at least 75% of their treatment period.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010532
  • 2015 Oct
  • NQF-Endorsed Measure

Antidepressant medication management (effective continuation phase treatment): percentage of members 18 years of age and older who were treated with antidepressant medication, had a diagnosis of major depression and who remained on an antidepressant medication for at least 180 days (6 months).

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010409
  • 2015 Jan

Pediatric preventive care: percentage of pediatric patients ages 12 to 17 years who have a documented mental health and/or depression screening using one of the specified validated tools at a well-child visit during the measurement period.

MN Community Measurement

  • Measure Summary
  • NQMC:010498
  • 2015 Oct
  • NQF-Endorsed Measure

Weight assessment and counseling for nutrition and physical activity for children/adolescents: percentage of members 3 to 17 years of age who had an outpatient visit with a PCP or OB/GYN and who had evidence of counseling for nutrition during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:010547
  • 2015 Oct
  • NQF-Endorsed Measure

Avoidance of antibiotic treatment in adults with acute bronchitis: percentage of adults 18 to 64 years of age with a diagnosis of acute bronchitis who were not dispensed an antibiotic prescription.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009332
  • 2012 Mar

Children at risk: percentage of children in the eligible population who turned age 1, 2 or 3 years who were screened for risk for developmental, behavioral and social delays using a standardized screening tool in the last 12 months.

Oregon Pediatric Improvement Partnership

  • Measure Summary
  • NQMC:010568
  • 2015 Oct
  • NQF-Endorsed Measure

Medical assistance with smoking and tobacco use cessation: percentage of members 18 years of age and older who were current smokers or tobacco users and who discussed or were recommended cessation medications during the measurement year.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:009340
  • 2012 Mar

Children at risk: percentage of children in the eligible population who turned age 1, 2 or 3 years identified at risk for developmental, behavioral and social delays who were referred for follow up.

Oregon Pediatric Improvement Partnership

  • Measure Summary
  • NQMC:010535
  • 2015 Oct
  • NQF-Endorsed Measure

Follow-up after hospitalization for mental illness: percentage of discharges for members 6 years of age and older who were hospitalized for treatment of selected mental illness diagnoses and who had an outpatient visit, an intensive outpatient encounter, or partial hospitalization with a mental health practitioner within 30 days of discharge.

National Committee for Quality Assurance

  • Measure Summary
  • NQMC:000227
  • 2002 Jan
  • NQF-Endorsed Measure

Preventive screening and counseling on emotional health and relationship issues: average proportion saying "yes" to six items about whether provider(s) discussed/screened for feeling sad or depressed, school performance, friends, suicide and sexual orientation.

Child and Adolescent Health Measurement Initiative

  • Measure Summary
  • NQMC:010501
  • 2015 Oct
  • NQF-Endorsed Measure

Immunizations for adolescents: percentage of adolescents 13 years of age who had one dose of meningococcal vaccine and one tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap) or one tetanus, diphtheria toxoids vaccine (Td) by their 13th birthday.

National Committee for Quality Assurance